Study linking depression to specific altered brain cells opens door to new treatments

keila.depape@mcgill.ca — Tue, 26 Aug 2025 19:24:20 +0000

Researchers at �� and the Douglas Institute have identified two specific types of brain cells that are altered in people with depression.

The study, published in Nature Genetics, opens the door to developing new treatments that target these cells and deepens our understanding of depression, a leading cause of disability worldwide that affects more than 264 million people.

�� study identifies new role of major genetic risk factor in Alzheimer’s disease

frederique.mazerolle@mcgill.ca — Fri, 20 Dec 2019 14:57:15 +0000

For years, physicians have been aware that patients carrying the apolipoprotein ꜫ4 (APOE ꜫ4) gene are at a greater risk of developing Alzheimer’s disease. New research from �� has now found the gene plays an even greater role in dementia.

Douglas Institute

Study linking depression to specific altered brain cells opens door to new treatments

������ study identifies new role of major genetic risk factor in Alzheimer’s disease

�� study identifies new role of major genetic risk factor in Alzheimer’s disease